These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 22616535)
1. [Renal affection in gout]. Egorov IV; Tsurko VV Ter Arkh; 2012; 84(1):65-8. PubMed ID: 22616535 [TBL] [Abstract][Full Text] [Related]
2. Hereditary nephropathy associated with hyperuricemia and gout. Puig JG; Miranda ME; Mateos FA; Picazo ML; Jiménez ML; Calvin TS; Gil AA Arch Intern Med; 1993 Feb; 153(3):357-65. PubMed ID: 8427538 [TBL] [Abstract][Full Text] [Related]
3. Current and future therapeutic options for the management of gout. Whelton A Am J Ther; 2010; 17(4):402-17. PubMed ID: 20562597 [TBL] [Abstract][Full Text] [Related]
4. Hyperuricemia and gout: an update. Khachadurian AK Am Fam Physician; 1981 Dec; 24(6):143-8. PubMed ID: 6895439 [TBL] [Abstract][Full Text] [Related]
5. Hyperuricemia, gout and the kidney. Gibson T Curr Opin Rheumatol; 2012 Mar; 24(2):127-31. PubMed ID: 22157498 [TBL] [Abstract][Full Text] [Related]
6. Drug therapy reviews: pathogenesis and clinical management of hyperuricemia and gout. Mangini RJ Am J Hosp Pharm; 1979 Apr; 36(4):497-504. PubMed ID: 433935 [No Abstract] [Full Text] [Related]
7. Does renal impairment protect from gout? Youssef P; Brama T; York H; Pickard P; Stewart P; McGill N J Rheumatol; 1995 Mar; 22(3):494-6. PubMed ID: 7783068 [TBL] [Abstract][Full Text] [Related]
9. Mulberroside a possesses potent uricosuric and nephroprotective effects in hyperuricemic mice. Wang CP; Wang Y; Wang X; Zhang X; Ye JF; Hu LS; Kong LD Planta Med; 2011 May; 77(8):786-94. PubMed ID: 21154198 [TBL] [Abstract][Full Text] [Related]
10. Uric acid--a uremic toxin? Nakagawa T; Mazzali M; Kang DH; Sánchez-Lozada LG; Herrera-Acosta J; Johnson RJ Blood Purif; 2006; 24(1):67-70. PubMed ID: 16361844 [TBL] [Abstract][Full Text] [Related]
11. [Hyperuricemia as a risk factor of nephropathy in gout]. Siniachenko OV; Diadyk AI; Nikolenko IuI; Vasilenko IV Ter Arkh; 1988; 60(1):97-101. PubMed ID: 3363519 [TBL] [Abstract][Full Text] [Related]
12. [Physiologic bases of the treatment of gout]. Gascon J Union Med Can; 1976 Apr; 105(4):610-5. PubMed ID: 997014 [No Abstract] [Full Text] [Related]
13. [Uninterrupted therapy of hyperuricemia and gout]. Schilling F Reumatizam; 1971; 18(3):79-82. PubMed ID: 5097291 [No Abstract] [Full Text] [Related]
14. [Hyperuricemia and the kidney]. Reutter F ZFA (Stuttgart); 1976 Feb; 52(4):193-6. PubMed ID: 1266328 [No Abstract] [Full Text] [Related]
16. Risk factors associated with renal lithiasis during uricosuric treatment of hyperuricemia in patients with gout. Perez-Ruiz F; Hernandez-Baldizon S; Herrero-Beites AM; Gonzalez-Gay MA Arthritis Care Res (Hoboken); 2010 Sep; 62(9):1299-305. PubMed ID: 20506124 [TBL] [Abstract][Full Text] [Related]
17. Renal clearance of uric acid is linked to insulin resistance and lower excretion of sodium in gout patients. Perez-Ruiz F; Aniel-Quiroga MA; Herrero-Beites AM; Chinchilla SP; Erauskin GG; Merriman T Rheumatol Int; 2015 Sep; 35(9):1519-24. PubMed ID: 25763991 [TBL] [Abstract][Full Text] [Related]
18. [Historical review of gout and hyperuricemia investigations]. Nakamura T Nihon Rinsho; 2008 Apr; 66(4):624-35. PubMed ID: 18409506 [TBL] [Abstract][Full Text] [Related]
19. Control of renal uric acid excretion and gout. Taniguchi A; Kamatani N Curr Opin Rheumatol; 2008 Mar; 20(2):192-7. PubMed ID: 18349750 [TBL] [Abstract][Full Text] [Related]